Wednesday, September 25, 2013

Here is what the Texas State Board of Pharmacy (TSBP) says about IV Solutions of Lubbock--It Shows Disciplinary Action!!! It says: IV Solutions of Lubbock, Pharmacy License No. 17088, Lubbock, TX. Alleged violation: dispensing error. Agreed Board Order accepted by licensee and entered by the Board on 05-08-12: license reprimanded; fined $1500; and must develop and implement a Continuous Quality Improvement Program (to include peer review) for purposes of preventing and handling dispensing errors. Language of Agreed Order Copied and Pasted At Bottom.


IV SOLUTIONS OF LUBBOCK

License Information

License Status
Active
License #
17088
Expiration Date
04/30/2014
Date License Issued
04/12/1996

Address

3706 A 20TH STREET
LUBBOCK, TX  79410
County
LUBBOCK
Phone
(806) 791-4663

Pharmacy Details

Prior Disciplinary Orders*   
Yes

View Order Details Below:
Class of Pharmacy
Community
Type of Ownership
Corporation
Type of Pharmacy
Other
# of Hospital beds
0
* Information relating to disciplinary orders is current as of (30 days prior to this date).
A written request for information regarding prior disciplinary orders may be submitted to the office of the Texas State Board of Pharmacy. Disciplinary orders entered pursuant to Chapter 564 of the Texas Pharmacy Act are confidential and not subject to disclosure.

Employment Information

Pharmacist in Charge
HEATON, JESSIE BRENT

Pharmacy Profile ¥

Accessible to disabled persons?
Yes
Participates in the Texas Medicaid program?
Yes
Participates in the Texas Kids Insurance Program (SKIP)?
No
Dispenses prescriptions in response to an Internet order?
No
Delivers prescription to a patient in this state?
No
Translating services
Spanish
Telecomm. for the deaf (TDD)
Other
¥ Please note: The data regarding accessibility, translating services, and insurance participation is self-reported by the license holder and no warranty regarding the information is created. Therefore, neither the State of Texas nor the licensing agency accept any legal liability or responsibility or may be held liable or responsible for the accuracy, completeness, timeliness, or usefulness of this information. Should you have any concern as to the accuracy of the data in this system, please contact the license holder or facility for clarification.

Services Provided

No
Nuclear
Yes
Out-Patient Sterile Products
No
Out-Patient/Discharge Prescriptions
Yes
Mail Service
No
Long Term Care
No
Class D (Expanded Formulary)
No
Class D (Alternative Visit Schedule)
Yes
Compounding Sterile-Risk Level Low
Yes
Compounding Sterile-Risk Level Med
No
Compounding Sterile-Risk Level High
No
Compounding Non-Sterile
No

AGREED BOARD ORDER #J-11-012 
RE:  IN THE MATTER OF 
IV SOLUTIONS OF LUBBOCK 
(PHARMACY LICENSE #17088) 
BEFORE THE TEXAS STATE 
BOARD OF PHARMACY 
On this  day  came on to  be considered by the Texas  State Board of Pharmacy the 
matter of pharmacy license  number  17088  issued  to  IV  Solutions  of Lubbock,  3706  A 
20th Street, Lubbock, Texas 79410. 
By letter dated July 29,  2011, the Texas State Board of Pharmacy gave preliminary 
notice to  IV  Solutions of Lubbock of its  intent to  take disciplinary action with respect to 
pharmacy  license  number  17088  issued  to  IV  Solutions  of Lubbock.  This  action  was 
taken as a result of an investigation which produced evidence indicating that IV Solutions 
of Lubbock may have violated: 
Section  565.001(a)(l),  (2)  and  (12);  and  Section  565.002(a)(3)  of  the 
Texas Pharmacy Act, TEx. Occ. CoDE ANN. Subtitle J (2005); and 
Section  281.7(a)(l2)  and  (13);  Section  291.26(c)(I)(B)(vii);  Section 
291.31 (I), (14) and (15); Section 291.32(a)(2)(H); Section 291.32( c )(I )(E) 
and (F);  Section 291.32(c)(2)(B)  and (D);  and Section 295.3  of the Texas 
Pharmacy Board Rules, 22 TEx. ADMIN. CODE (2007), in that,  allegedly: 
COUNT 
On  or  about  March  20,  2007,  Robby  Don  Timberlake,  while  acting  as  an 
employee  (pharmacist-in-charge)  of  IV  Solutions  of  Lubbock,  3706  A  20'h  Street, 
Lubbock,  Texas  79410,  dispensed  to  patient  J.K.  a  compounded  preparation  of 
colistimethate 75mg  per  3m!  0.225% NaCI  in  plastic  ampules with  directions  to  "inhale 
the  contents of I  ampule  (75mg)  via  eFlow twice  daily  as  directed."  A  quantity of 60 
plastic  ampules was supplied to  patient J.K.  The  prescription that was  issued to  J.K.,  a 
cystic fibrosis patient, called for colistimethate 150mg/6ml in sterile water with directions 
to  "add 3m!  (75mg)  of colistimethate  and  lml of Bronchosaline  to  eFlow  and  nebulize 
twice  daily as  directed."  The prescription indicated a quantity of 30.  On or about April 
26,  2007,  patient  J.K.  began  therapy  as  instructed  by  the  prescription's  label.  The 
prescription was assigned prescription number 20008265. Agreed Board Order #J-11-0 12 
IV Solutions of Lubbock 
Pagel 
An  informal  conference  was  held  in  the  office  of the  Texas  State  Board  of 
Pharmacy  on  September  7,  2011,  with  George  Carlisle  Birdsong,  R.Ph.,  Corporate 
President of Max or National Pharmacy Services,  on behalf of IV  Solutions of Lubbock, 
and  Hector De  Leon,  Legal  Counsel  for  IV  Solutions  of Lubbock,  in  attendance.  The 
informal  conference  was  heard  by a Board panel  comprised  of:  Jeaune  D.  Waggener, 
R.Ph.,  Board  Member;  Gay  Dodson,  R.Ph.,  Executive  Director/Secretary;  and  Carol 
Fisher,  R.Ph.,  M.P.A.,  Director  of  Enforcement;  with  Kerstin  E.  Arnold,  General 
Counsel.  Linda K. Townsend, Staff Attorney, was  also in attendance. 
At the  aforementioned  conference,  Hector De Leon stated  he was present for  and 
on behalf ofiV Solutions of Lubbock. 
Subsequent to the informal conference, IV Solutions of Lubbock retained Julian L. 
Rivera as its Legal Counsel. 
By George Carlisle Birdsong's  appearance  at  the  informal  conference,  and by his 
signature  and  Julian  L.  Rivera's signature on this  Order,  George Carlisle Birdsong and 
Julian  L.  Rivera  agree  that  the  Texas  State Board  of Pharmacy  has jurisdiction in  this 
matter,  and  do  hereby  waive  the  right  to  notice  of hearing,  to  a  formal  administrative 
hearing, and to judicial review of this Order. 
After discussion  of the matters  previously outlined  in this  Order,  and subsequent 
communications,  George  Carlisle  Birdsong  and  Julian  L.  Rivera,  on  behalf  of  IV 
Solutions of Lubbock,  agreed  to  the  entry of an Order disposing of the  need for  further 
disciplinary  action  in  this  matter.  By  their  signatures  on  this  Order,  George  Carlisle 
Birdsong and Julian L.  Rivera neither admit nor deny the truth of the  matters previously 
set out in this Order with respect to the above alleged violations. Agreed Board Order #J-11-0 12 
IV Solutions of Lubbock 
Page3 
Should  this  Order  not  be  accepted  by  the  Board,  it  is  agreed  that  neither  the 
presentation of the Order to the Board nor the Board's consideration of the Order, will be 
deemed to  have unfairly or illegally prejudiced the Board or its individual members and, 
therefore,  will  not be  grounds for  precluding the  Board or any individual member of the 
Board  from  further  participation  in  proceedings  related  to  the  matters  set  forth  in  the 
Order. 
George  Carlisle  Birdsong  and  Julian  L.  Rivera,  on  behalf of IV  Solutions  of 
Lubbock,  understand that any failure to  comply with the terms of this Order is a basis for 
discipline under the Texas Pharmacy Act. 
At  the  conclusion  of  the  aforementioned  conference,  and  subsequent 
communications,  it  was  agreed  among  the  parties  that  IV  Solutions  of Lubbock  shall 
comply with the terms and conditions set forth in the ORDER OF THE BOARD below. 
ORDER OF THE BOARD 
THEREFORE,  PREMISES  CONSIDERED,  the  Texas  State  Board  of Pharmacy 
(hereinafter  referred  to  as  "BOARD")  does  hereby  ORDER  that  pharmacy  license 
number 17088 held by IV Solutions of Lubbock (hereinafter referred to  as  "Respondent") 
shall be, and such license is hereby reprimanded. 
It  is  further  ORDERED  that  Respondent  shall  develop  and  implement  policies 
and  procedures  for  a  Continuous  Quality  Improvement  Program  for  purposes  of 
preventing  and  handling  dispensing  errors.  The  Continuous  Quality  Improvement 
Program shall include pharmacist peer review in compliance with gu

No comments: